Literature DB >> 8396592

Tentative interpretive criteria for disk diffusion susceptibility testing of sparfloxacin.

P C Fuchs1, A L Barry, M A Pfaller.   

Abstract

Susceptibility to sparfloxacin was tested simultaneously by the agar dilution and disk diffusion methods. For tests with 5-micrograms sparfloxacin disks, we propose that the breakpoints for the susceptibility and resistance categories should be > or = 19 and < or = 15 mm, respectively. Most minor discrepancies involved tests with pseudomonads.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8396592      PMCID： PMC265733          DOI： 10.1128/jcm.31.8.2236-2237.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  6 in total

1.  Pharmacokinetics and inflammatory fluid penetration of sparfloxacin.

Authors:  J H Johnson; M A Cooper; J M Andrews; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

2.  The penetration of sparfloxacin into human plasma and skin tissues.

Authors:  T Nogita; Y Ishibashi
Journal:  J Antimicrob Chemother       Date:  1991-08       Impact factor: 5.790

3.  In vitro activity of sparfloxacin (AT-4140, CI-978, PD 131501), a new quinolone antimicrobial agent.

Authors:  G M Eliopoulos; K Klimm; M L Grayson
Journal:  Diagn Microbiol Infect Dis       Date:  1990 Jul-Aug       Impact factor: 2.803

4.  In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent.

Authors:  M A Cooper; J M Andrews; J P Ashby; R S Matthews; R Wise
Journal:  J Antimicrob Chemother       Date:  1990-11       Impact factor: 5.790

5.  Interpretive criteria for disk diffusion susceptibility testing of sparfloxacin.

Authors:  F H Kayser; J Wüst
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-03       Impact factor: 3.267

6.  In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin.

Authors:  A L Barry; P C Fuchs
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191
  6 in total
  1 in total

1.  Suggested modifications for disk diffusion susceptibility testing criteria for levofloxacin and sparfloxacin following tests with a predictor panel of ciprofloxacin-resistant clinical isolates.

Authors:  L D Sutton; R N Jones
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.